State Street Corp Vertex Pharmaceuticals Inc Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 11,775,227 shares of VRTX stock, worth $4.65 Billion. This represents 0.2% of its overall portfolio holdings.
Number of Shares
11,775,227
Previous 11,788,657
0.11%
Holding current value
$4.65 Billion
Previous $5.72 Billion
8.28%
% of portfolio
0.2%
Previous 0.24%
Shares
22 transactions
Others Institutions Holding VRTX
# of Institutions
1,810Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$11.3 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.46 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.41 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.36 Billion1.5% of portfolio
-
Jpmorgan Chase & CO New York, NY7.76MShares$3.06 Billion0.29% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $101B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...